Adipocyte‐specific deletion of Mettl14 increases adipose lipolysis and protects against HFD‐induced obesity, insulin resistance, and nonalcoholic fatty liver disease (NAFLD). This evidence concerns the gene METTL14 and obesity due to melanocortin 4 receptor deficiency.